FDAnews Announces — Combination Products and Cross-Center Reviews: Examining the Regulatory Pathway for Complex Products Under the 21st Century Cures Act Webinar, March 21

The 21st Century Cures Act adds an extensive new set of statutory provisions intended to provide greater consistency in the FDA’s regulation of combination products and procedural remedies to ensure the optimal review of combination products. Join David M. Fox — Partner, Hogan Lovells — on March 21 for a close look at the FDA’s new authority governing combination products and several new provisions under the 21st Century Cures Act that could usher in a new era of interdisciplinary product reviews at the FDA.(PRWeb March 09, 2017)Read the full story at http://www.prweb.com/releases/FDAnews/crosscenter/prweb14132891.htm